In February 1986, the U.S. Food and Drug Administration (FDA) approved Hybritech’s Tandem-R PSA assay (P850048) with calibration linked to an established internal reference preparation of human PSA purified from seminal plasma.  This was the first antibody test approved for prostate cancer.